Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial

Bibliographic Details
Title: Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial
Authors: Natsuo Tomita, Hiromichi Ishiyama, Chiyoko Makita, Yukihiko Ohshima, Aiko Nagai, Fumiya Baba, Mayu Kuno, Shinya Otsuka, Takuhito Kondo, Chikao Sugie, Tatsuya Kawai, Taiki Takaoka, Dai Okazaki, Akira Torii, Masanari Niwa, Nozomi Kita, Seiya Takano, Shogo Kawakami, Masayuki Matsuo, Tomoyasu Kumano, Makoto Ito, Sou Adachi, Souichiro Abe, Takayuki Murao, Akio Hiwatashi
Source: BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Publisher Information: BMC, 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Brain metastases, Radiation biology, Stereotactic radiation, Treatment outcome, Clinical Trial, Phase II, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background Radiobiological daily changes within tumors are considered to be quite different between stereotactic radiotherapy (SRT) (e.g., 50 Gy in 4 fractions) and conventional radiotherapy (e.g., 60 Gy in 30 fractions). We aim to assess the optimal interval of irradiation in SRT and compare outcomes of daily irradiation with irradiation at two- to three-day intervals in SRT for patients with one to five brain metastases (BM). Methods This study is conducted as a multicenter open-label randomized phase II trial. Patients aged 20 or older with one to five BM, less than 3.0 cm diameter, and Karnofsky Performance Status ≥70 are eligible. A total of 70 eligible patients will be enrolled. After stratifying by the number of BMs (1, 2 vs. 3–5) and diameter of the largest tumor (
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1471-2407
Relation: https://doaj.org/toc/1471-2407
DOI: 10.1186/s12885-022-10371-3
Access URL: https://doaj.org/article/16409df8bb6e4e7d9dd81fac79276979
Accession Number: edsdoj.16409df8bb6e4e7d9dd81fac79276979
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14712407
DOI:10.1186/s12885-022-10371-3
Published in:BMC Cancer
Language:English